Evidence map›Paper›PMID 41667553›Full record

ArticleScientific reports2026

meso-2,3-dibromosuccinic acid as a temperature-dependent catalyst for the selective synthesis of syn and anti-highly functionalized tetrahydropyridines: experimental and theoretical study.

Jasem Aboonajmi, Zeinab Mandegani, Jaber Tajodini Rabor, Dariush Khalili, Mohammad Manassir, Pezhman Shiri, Malek Taher Maghsoodlou

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jasem AboonajmiDepartment of Chemistry, College of Sciences, Shiraz University, Shiraz, 71454, Iran. j.aboonajmi.ch@gmail.com.
Zeinab MandeganiDepartment of Chemistry, College of Sciences, Shiraz University, Shiraz, 71454, Iran.
Jaber Tajodini RaborDepartment of Chemistry, College of Sciences, Shiraz University, Shiraz, 71454, Iran.
Dariush KhaliliDepartment of Chemistry, College of Sciences, Shiraz University, Shiraz, 71454, Iran. khalili@shirazu.ac.ir.
Mohammad ManassirDepartment of Chemistry, College of Sciences, Shiraz University, Shiraz, 71454, Iran.
Pezhman ShiriDepartment of Chemistry, College of Sciences, Shiraz University, Shiraz, 71454, Iran.
Malek Taher MaghsoodlouDepartment of Chemistry, College of Sciences, Sistan and Baluchestan University, Zahedan, Iran.

Funding

Dariush Khalili Grant no. 3GRC1M235307
6 · The paper itself

Abstract

This study reports the flexible synthesis of syn-anti isomers of highly functionalized tetrahydropyridines under controlled temperature conditions. The present catalytic system employs cost-effective meso-2,3-dibromosuccinic acid in a one-pot, multicomponent process involving both aromatic aldehydes, anilines, and 1,3-dicarbonyl compounds to produce a structurally diverse tetrahydropyridines. The current catalyst, meso-2,3-dibromosuccinic acid, demonstrates a unique capability for selective synthesis of syn:anti tetrahydropyridine isomers. Unlike other reported catalysts, it enables exclusive formation of the syn isomer at low temperatures (5 °C) and allows tunable syn:anti ratios at moderate temperatures (25 °C). Moreover, at 65 °C, meso-2,3-dibromosuccinic acid exclusively yields the anti isomer highlighting its distinct advantage in controlling product selectivity. Other notable features of this method include simple work-up procedure, the absence of transition metal catalysts, high structural diversity of the products, and excellent product yields. Thermodynamics, kinetics, aromaticity, frontier orbitals, and

Indexed as

KineticsMeso-2,3-dibromosuccinic acidMetal-freeMulticomponent reactionsyn/anti formsTemperature-controlled systemTetrahydropyridineThermodynamics

Identifiers

PMID41667553
PMCPMC12960815

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.